Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.58 |
| ▸ | CNR2 | P34972 | 11/20 | 0.50 |
| ▸ | CNR1 | P21554 | 10/20 | 0.50 |
| ▸ | GBA1 | P04062 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8595923 | 1.00 | FAAH (0.58) | FAAHCNR2CNR1GBA1HSP90AA1 | |
| SCHEMBL8596053 | 1.00 | FAAH (0.58) | FAAHCNR2CNR1GBA1HSP90AA1 | |
| SCHEMBL8596047 | 1.00 | FAAH (0.58) | FAAHCNR2CNR1GBA1HSP90AA1 | |
| SCHEMBL8599738 | 1.00 | FAAH (0.58) | FAAHCNR2CNR1GBA1HSP90AA1 | |
| SCHEMBL8599735 | 1.00 | FAAH (0.58) | FAAHCNR2CNR1GBA1HSP90AA1 | |
| SCHEMBL8595918 | 1.00 | FAAH (0.58) | FAAHCNR2CNR1GBA1HSP90AA1 | |
| SCHEMBL8599036 | 0.98 | FAAH (0.59) | FAAHCNR2CNR1GBA1 | |
| SCHEMBL8599031 | 0.98 | FAAH (0.59) | FAAHCNR2CNR1GBA1 | |
| SCHEMBL8595463 | 0.94 | FAAH (0.57) | FAAHCNR2CNR1 | |
| SCHEMBL8595466 | 0.94 | FAAH (0.57) | FAAHCNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210001023-A1 | EXTRACORPOREAL DEVICE AND MATRIX FOR REMOVING FIBRINOLYTIC PROTEINS FROM BIOLOGICAL FLUIDS, METHODS AND USES THEREOF | PLAS-FREE LTD (IL) | 2021-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210001023-A1 | EXTRACORPOREAL DEVICE AND MATRIX FOR REMOVING FIBRINOLYTIC PROTEINS FROM BIOLOGICAL FLUIDS, METHODS AND USES THEREOF | PLG, FGB, PLAU | FAAH 99/4885CNR2 1699/4885CNR1 1596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.